Latest filing published 14 Sept 2026 for Curaleaf Holdings, Inc., €21k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Peter Laurence Clateman in Curaleaf Holdings, Inc. In total, 37 filings cover trades dated from 28 May 2026 to 9 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 14 September 2026: a share grant of €21k, in Curaleaf Holdings, Inc. Between a trade and the moment it shows up on SEDI, the median delay is 5 days. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 37 declarations
Curaleaf’s chief legal officer bought on July 17 as cannabis policy momentum, listed options, and peer activity frame th...
Curaleaf is consolidating near recent levels as Peter Laurence Clateman bought shares again. Here is what the filing mea...